Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine effects on Sleep EEG in Schizophrenia
NCT01149577Phase 4Completed
- Sponsor
- Central Institute of Psychiatry
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of olanzapine in schizophrenia, sponsored by Central Institute of Psychiatry. Primary endpoint: Sleep Electroencephalogram at 6 weeks. Started Aug 2007; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01149577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149577.